Did you mean ertugliflozin pivalate and sitagliptin phosphate?
Displaying drugs 13051 - 13075 of 14388 in total
Leuvectin
Leuvectin (formerly known as VCL-1102) is a component of gene therapy along with cationic lipid 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE).
Investigational
KTH-222
Investigational
Belzupacap Sarotalocan
Investigational
ADXS-31164
Investigational
Eltrapuldencel-T
Investigational
Inalimarev
Investigational
IMGN779
Investigational
ICG-140
Investigational
MORAb-066
MORAb-066 is a humanized antibody directed against tissue factor (TF). It is being investigated in pancreatic cancer.
Investigational
OBI-999
Investigational
STM-217
Investigational
Autologous DNP-conjugated tumour vaccine
Autologous DNP-conjugated tumour vaccine, or melanoma vaccine, is an investigational autologous cell vaccine technology for melanoma.
Investigational
RR001
RR001 is an investigational gene therapy consisting of autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand (AD-PC sTRAIL).
Investigational
P-BCMA-101
P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.
Investigational
Bersanlimab
Bersanlimab is an investigational monoclonal antibody directed against intercellular adhesion molecule 1 (ICAM-1).
Investigational
WTx-Bortezomib
Experimental
SurVaxM
Investigational
Belagenpumatucel-L (NCI H-520)
Investigational
Belagenpumatucel-L (RH 2)
Investigational
PAT-SM6
Investigational
SCH-58500
SCH-58500 is a recombinant replication-deficient adenovirus vector carrying the human p53 gene.
Investigational
VXM01
Investigational
KAHR-102
KAHR-102 is a dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL).
Investigational
ERC-1671
Investigational
Displaying drugs 13051 - 13075 of 14388 in total